UnitedHealth Group Incorporated $UNH Position Lessened by Relyea Zuckerberg Hanson LLC

Relyea Zuckerberg Hanson LLC lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.7% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 3,554 shares of the healthcare conglomerate’s stock after selling 662 shares during the quarter. Relyea Zuckerberg Hanson LLC’s holdings in UnitedHealth Group were worth $1,109,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the stock. Nuveen LLC bought a new position in shares of UnitedHealth Group in the first quarter worth about $3,846,764,000. Vanguard Group Inc. grew its stake in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the period. Wellington Management Group LLP increased its position in shares of UnitedHealth Group by 10.6% during the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares in the last quarter. National Bank of Canada FI increased its holdings in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate’s stock valued at $859,518,000 after purchasing an additional 950,928 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock valued at $3,702,736,000 after acquiring an additional 847,054 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

UNH stock opened at $360.17 on Monday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company’s 50-day moving average price is $307.84 and its two-hundred day moving average price is $353.45. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $326.20 billion, a P/E ratio of 15.61, a P/E/G ratio of 2.34 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Morgan Stanley lifted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Barclays boosted their price target on UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 30th. Finally, JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.